Iodide

Iodide

SCHEMBL4083174

C[N+](C)(C)CC(O)CO.[I-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 2/20 0.32
CHRM3 known ✓ P20309 1/20 0.31
LMNA P02545 4/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 2/20 0.44
SLC22A16 Q86VW1 1/20 0.44
THRB P10828 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.34
PSMD14 O00487 1/20 0.33
PLA2G1B P04054 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MMP2 P08253 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
TSHR P16473 3/20 0.32
CHRM2 P08172 2/20 0.32
CHRM4 P08173 2/20 0.32
TBXA2R P21731 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35947 0.97
SCHEMBL9819526 0.97
SCHEMBL6667882 0.97
Water SCHEMBL4330053 0.94 LMNA (0.47) LMNAALDH1A1MAPTSLC22A16THRB
Hydrochloric Acid SCHEMBL35525 0.94 MAPT (0.50) LMNAALDH1A1MAPTSLC22A16THRB
Bromide SCHEMBL8408095 0.94 LMNA (0.47) LMNAALDH1A1MAPTSLC22A16THRB
Hydrochloric Acid SCHEMBL9819532 0.94 MAPT (0.50) LMNAALDH1A1MAPTSLC22A16THRB
Ammonia Solution, Strong SCHEMBL27633517 0.91 MAPT (0.48) LMNAALDH1A1MAPTSLC22A16THRB
Ethylene Glycol SCHEMBL3142993 0.88 MAPT (0.46) LMNAALDH1A1MAPTSLC22A16THRB
SCHEMBL28282530 0.88 LMNA (0.42) LMNAALDH1A1MAPTSLC22A16THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10449483-B2 Gas sweetening solvents containing quaternary ammonium salts DOW GLOBAL TECHNOLOGIES LLC (US) 2019-10-22 US claimed
US-20160206992-A1 GAS SWEETENING SOLVENTS CONTAINING QUATERNARY AMMONIUM SALTS DOW GLOBAL TECHNOLOGIES LLC 2016-07-21 US claimed
EP-3038736-A1 GAS SWEETENING SOLVENTS CONTAINING QUATERNARY AMMONIUM SALTS Dow Global Technologies LLC (US) 2016-07-06 EP claimed
EP-1086072-B1 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF UNIV MICHIGAN STATE (US) 2006-10-18 EP claimed
EP-1086072-A4 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF UNIV MICHIGAN STATE (US) 2004-12-22 EP claimed
EP-1086072-A1 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF MICHIGAN STATE UNIVERSITY (US) 2001-03-28 EP claimed
US-6084131-A Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) 2000-07-04 US claimed
WO-1999062863-A1 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF MICHIGAN STATE UNIVERSITY (US) 1999-12-09 WO claimed
US-10449483-B2 Gas sweetening solvents containing quaternary ammonium salts DOW GLOBAL TECHNOLOGIES LLC (US) 2019-10-22 US disclosed
US-20160206992-A1 GAS SWEETENING SOLVENTS CONTAINING QUATERNARY AMMONIUM SALTS DOW GLOBAL TECHNOLOGIES LLC 2016-07-21 US disclosed
EP-3038736-A1 GAS SWEETENING SOLVENTS CONTAINING QUATERNARY AMMONIUM SALTS Dow Global Technologies LLC (US) 2016-07-06 EP disclosed
US-7507859-B2 Functional synthetic molecules and macromolecules for gene delivery FIFTH BASE LLC (US) 2009-03-24 US disclosed
US-20060241071-A1 Functional synthetic molecules and macromolecules for gene delivery FIFTH BASE LLC 2006-10-26 US disclosed
EP-1086072-B1 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF UNIV MICHIGAN STATE (US) 2006-10-18 EP disclosed
EP-1086072-A1 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF MICHIGAN STATE UNIVERSITY (US) 2001-03-28 EP disclosed
US-6084131-A Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) 2000-07-04 US disclosed
WO-1999062863-A1 PROCESS FOR THE PREPARATION OF PROTECTED DIHYDROXYPROPYL TRIALKYLAMMONIUM SALTS AND DERIVATIVES THEREOF MICHIGAN STATE UNIVERSITY (US) 1999-12-09 WO disclosed
EP-0257619-B1 PROCESS FOR PREPARING 3-HALOGENO-2-HYDROXYPROPYLTRIMETHYLAMMONIUM HALIDE KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1991-07-31 EP disclosed
US-4814506-A Process for preparing 3 halogeno-2-hydroxypropyltrimethylammonium halide KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1989-03-21 US disclosed
EP-0257619-A2 Process for preparing 3-halogeno-2-hydroxypropyltrimethylammonium halide KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1988-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241071-A1 Functional synthetic molecules and macromolecules for gene delivery ANXA6, STING1, POLRMT CHRM1 3636/4885CHRM3 3171/4885LMNA 953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.